Biotech news
Pharma
Personalised healthcare is a rapidly developing field, not just because of medical advancements, but also because the criteria necessary to secure second medical use patents has similarly evolved over the years, an industry webinar heard. 13 September 2018
Americas
Boston-based Nutter McClennen & Fish has added a team of IP professionals: three partners, two of counsels, one associate, and one technical specialist. 13 September 2018
Americas
Lino Almazan-Monroy and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril discuss how inventors seeking patents for polymorphs in Mexico can give themselves the best chance of success. 11 September 2018
Biotech
Biotech company Shire yesterday revealed plans to acquire a Switzerland-based plasma collection company. 7 September 2018
Americas
US-based Gilead announced Tuesday, September 4 that it has entered into a licensing agreement with biotech company Trianni for an undisclosed sum. 6 September 2018
Americas
A well-functioning linkage system for patents and drugs allows healthcare and patent authorities to maximise the impact of innovation, say Hector Chagoya and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril, who report on the Mexican landscape. 6 September 2018
Americas
Mexico has international depositary authority (IDA) status under the Budapest Treaty, which speeds up the patent process for microorganisms. Mariana Gonzalez-Vargas of Becerril, Coca & Becerril reviews the impact of the IDA on biotech patents in the country. 5 September 2018
Americas
A proposal in the North American Free Trade Agreement to set the length of biologic data exclusivity at ten years would harm patients, according to generic associations. 31 August 2018
Americas
A report released this week by non-profit MassBio has shown that Massachusetts companies “dominated” the landscape for US initial public offerings (IPOs) of biotech companies in 2017. 31 August 2018
Americas
Christopher Viehbacher was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 31 August 2018